AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Insights into Cardiovascular Drug Research and Findings
This chapter explores the SCORD trial, a significant study involving over 10,000 diabetes and kidney disease patients that assessed the impact of sodagliflozin. It also discusses ongoing research on lipoprotein A and an innovative injectable drug by Amgen, shedding light on new cardiovascular treatment avenues.